Carl H. June
Hospital of the University of Pennsylvania · 1,432 works · 148,871 citations · h-index 180
Top works
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- The B7 and CD28 receptor families
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- Regulation of Lymphokine Messenger RNA Stability by a Surface-Mediated T Cell Activation Pathway
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
- T-Cell Proliferation Involving the CD28 Pathway Is Associated witH Cyclosporine-Resistant Interleukin 2 Gene Expression
- Role of the CD28 receptor in T-cell activation
- CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.
- Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
- Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
- Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation.
- Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction.
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
- Cytokine release syndrome in severe COVID-19
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation